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Summary
Shh-Gli signaling controls cell fates in the developing
ventral neural tube by regulating the patterned expres-
sion of transcription factors in neural progenitors.
However, the molecular mechanisms that limit tar-
get gene responses to specific domains are unclear.
Here, we show that Wnt pathway inhibitors regulate
the threshold response of a ventral Shh target gene,
Nkx2.2, to establish its restricted expression in the
ventral spinal cord. Identification and characterization
of an Nkx2.2 enhancer reveals that expression is di-
rectly regulated by positive Shh-Gli signaling and neg-
ative Tcf repressor activity. Our data indicate that the
dorsal limit of Nkx2.2 is controlled by Tcf4-mediated
transcriptional repression, and not by a direct require-
ment for high-level Shh-Gli signaling, arguing against
a simple model based on differential Gli factor affini-
ties in target genes. These results identify a transcrip-
tional mechanism that integrates graded Shh and Wnt
signaling to define progenitor gene expression do-
mains and cell fates in the neural tube.
Introduction
During embryogenesis, tissue patterning and cell type
diversification are largely controlled by interactions be-
tween secreted signaling proteins that provide posi-
tional information and transcription factors that mediate
the molecular genetic responses to enact cell type-spe-
cific differentiation programs. In developing embryos
across many species, the secreted Hedgehog (Hh) pro-
teins serve critical roles in establishing tissue polarity
and cell fates (McMahon et al., 2003; Zhu and Scott,
2004). Studies in both flies and vertebrates indicate
that Hh functions in a graded manner, with different
cell types being induced at particular concentration
thresholds (Ingham and McMahon, 2001). Critical to
our understanding of this process is the elucidation of
the mechanisms by which cells within Hh-patterned
tissues translate extracellular Hh signals into distinct
transcriptional responses. In the developing vertebrate
spinal cord, the formation and patterning of ventral cell
*Correspondence: matisemp@umdnj.edutypes is under the control of Sonic hedgehog (Shh),
one of three vertebrate homologs of the Drosophila Hh
protein (Roelink et al., 1994). Shh is produced by cells
of the notochord and floor plate at the ventral midline
and is thought to diffuse dorsally within the neural tube
to generate a decreasing activity gradient (Jessell,
2000; Gritli-Linde et al., 2001; McMahon et al., 2003;
Briscoe and Ericson, 2001). Five primary neuronal clas-
ses have been identified ventrally (V3, MN, V2, V1, VO
from ventral to dorsal), each deriving from a unique
and characteristic progenitor domain (designated p3,
pMN, etc.) expressing specific combinations of homeo-
domain (HD) or basic helix-loop-helix (bHLH)-containing
transcription factors (see Figure 1A). Progenitor factors
can be subdivided into two groups based on their re-
sponse to Shh: ‘‘Class II’’ proteins are induced by Shh,
while ‘‘Class I’’ proteins are repressed by high-level
Shh activity and are generally located dorsal to Class II
proteins (Briscoe et al., 2000). The sharpening of pro-
genitor domain boundaries is thought to be achieved
through crossrepressive interactions between specific
Class I and Class II factors expressed in adjacent do-
mains (Briscoe et al., 2000; Muhr et al., 2001; reviewed
in Jessell, 2000, Briscoe and Ericson, 2001, and Lee
and Pfaff, 2001).
Despite abundant evidence that Shh has a critical role
in regulating the expression of ventral genes, the mech-
anisms that link morphogenetic Shh signaling to pro-
genitor gene expression are poorly understood. In verte-
brates, Gli proteins are the primary transcriptional
mediators of Shh target genes (Ruiz i Altaba, 1999;
Ingham and McMahon, 2001). Previous studies have
shown that all three Gli proteins (Gli1–3) contribute pos-
itive activator (GliACT) functions to the transduction of
the Shh signal in the ventral spinal cord; Gli2 has been
shown to play the predominant role in mediating the ini-
tial Shh signal, while Gli3 and Gli1 have been shown to
make smaller contributions (Bai et al., 2004; Lei et al.,
2004). Recent gain-of-function experiments indicate
that both Gli2ACT and Gli3ACT can induce many ventral,
Shh-dependent genes cell autonomously (Lei et al.,
2004; Stamataki et al., 2005), while overexpression of
Gli3ACT at different levels has been shown to induce dis-
tinct ventral cell fates in a manner analogous to varying
Shh concentrations in tissue culture assays (Stamataki
et al., 2005; Ericson et al., 1997a).
Collectively, these data suggest a model in which dis-
tinct extracellular levels of Shh are translated into pro-
portional nuclear Gli protein activity levels to control
the differential expression of progenitor target genes,
whose products subsequently act autonomously to
sharpen domain boundaries and establish unique neu-
ronal fates. One general principle that has emerged is
that many crossrepressive interactions that mediate
progenitor domain boundary formation involve Gro/
TLE corepressors, although there are exceptions (Muhr
et al., 2001; Lee and Pfaff, 2001). However, while some
repressive interactions occur reciprocally between pairs
of factors sharing a boundary, the interactions seem to
be less direct for others. For example, three factors
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326Figure 1. Gli Activators Induce both V3 and MN Progenitors at High Levels
(A) Schematic showing neuronal domains in the ventral spinal cord in relation to sources of Shh in midline structures. Five neuronal progenitor
domains are established under the direction of Shh via a hypothetical combination of Gli activator and Gli repressor activities.
(B) Schematic illustrating crossrepressive genetic interactions in the ventral neural tube that establish the p3/pMN/p2 progenitor domains.
(C) Schematic showing constructs used in the experiments detailed in (D)–(J).
(D–J) Transfection of DN-Gli2ACT into progenitor cells in the developing chick spinal cord using in ovo electroporation. The panel at the right
shows a GFP expression overlay, and the blue bolt indicates the transfected side in all panels. (D) DN-Gli2ACT induces the p3 marker Nkx2.2
(Lei et al., 2004). (E and F) The pMN markers Olig2 and Mnr2 are also induced by DN-Gli2ACT transfections. (G) Lhx3, which marks both pMN
and p2 progenitor cells, is induced by DN-Gli2ACT. (H–J0) Some cells tranfected with DN-Gli2ACT coexpress p3 (Nkx2.2) and pMN (Olig2, Mnr2)
markers (yellow cells marked by arrowheads). (H0), (I0), and (J0) show enlargements of the boxed areas in (H), (I), and (J), respectively.
(K) Summary of ventral genes induced by DN-Gli2ACT.have been shown to play a role in distinguishing the V3
and motoneuron progenitor (p3, pMN) domains: Nkx2.2
(p3), Olig2 (pMN), and Pax6 (pMN) (Ericson et al., 1997b;
Briscoe et al., 1999; Novitch et al., 2001). Nkx2.2
(a ‘‘Class II’’ factor) sets the ventral limit of the pMN
domain by repressing both Pax6 and Olig2 through
recruitment of Gro/TLE corepressors (Briscoe et al.,
1999; Muhr et al., 2001). In contrast, only Pax6 (a ‘‘Class
I’’ factor), but not Olig2 (a ‘‘Class II’’ factor), can suppress
Nkx2.2 expression at the p3/pMN boundary (Novitch
et al., 2001). However, Pax6 lacks a Gro/TLE binding mo-
tif and seems to function as an activator in this role, even
though repression of Nkx2.2 involves a Gro/TLE co-
repressor-dependent mechanism (Muhr et al., 2001).
These observations suggest that an unidentified tran-
scriptional repressor negatively regulates Nkx2.2 ex-
pression downstream of Pax6 to establish the dorsal
limit of the p3 domain (Figure 1B). Because this and other
key factors have not yet been identified, it has remainedunclear whether graded Shh-Gli signaling alone is suf-
ficient to control the restricted expression of ventral
progenitor genes and direct neuronal patterning in the
ventral neural tube.
In the current study, we provide evidence that inhibi-
tory components of the Wnt pathway function in concert
with graded Shh-Gli signaling to establish the p3/pMN
boundary in the developing vertebrate spinal cord.
Studies of Pax6, sFRP2, and Pax6;Gli2 mouse mutants,
as well as functional experiments in chick embryos, indi-
cate that Pax6 represses Nkx2.2 expression in pMN
cells by regulating the spatially restricted expression
of sFRP2, an extracellular inhibitor of Wnt signaling,
and Tcf4, a member of the Tcf/Lef family of transcrip-
tional mediators of canonical Wnt signaling (Galli et al.,
2006; Kawano and Kypta, 2003; Hurlstone and Clevers,
2002). Our results indicate that Wnt pathway inhibitors
control the threshold response of Nkx2.2 to graded mor-
phogenetic Shh-Gli signaling information, and they
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327suggest a transcriptional mechanism that integrates
graded Shh and Wnt signaling to regulate patterning
and cell fate specification in the ventral neural tube.
Results
Gli Activators Can Induce both V3 and Motoneuron
Progenitor Markers
To study the generation of ventral cell types by Gli acti-
vator proteins (GliACT), we transfected an N-terminally
truncated (DN) Gli2 construct that functions as a consti-
tutive Shh pathway activator (Sasaki et al., 1999) into
chick neural progenitors shortly after neural tube clo-
sure and monitored the fate of induced cells (Lei et al.,
2004). Transfection of DN-Gli2ACT consistently resulted
in the induction of markers of both p3 (Nkx2.2) and
pMN (Olig2, Mnr2, Lhx3) cells (Figures 1D–1G) (Lei
et al., 2004). Notably, many induced cells exhibited a hy-
brid identity, coexpressing p3 (Nkx2.2) and pMN (Mnr2,
Olig2) markers at 24 hr posttransfection (hpt) (Figures 1H
and 1I), while Nkx2.2 and Mnr2, but not Olig2, were still
coexpressed at 48 hpt (data not shown). These marker
combinations are not normally seen at spinal cord levels
in normal, untransfected chicken embryos at these
stages. Because Gli2ACT can induce both Nkx2.2 and
Olig2, these results suggest that repression of Olig2 by
Nkx2.2 may be overridden in cells in which both genes
are being strongly driven by a high level of GliACT signal-
ing. In contrast, Nkx2.2 and Pax6 were not coexpressed,
consistent with the observation that Pax6 is not posi-
tively regulated by high levels of Shh-Gli signaling
(Figure 1J) (Briscoe et al., 2000). Together, these data
show that the ectopic activation of ventral genes by
Gli2ACT does not fully resolve into pMN and p3 fates,
suggesting that additional factors are required to fulfill
this function.
Rescue of V3 Progenitors in the Thoracic Region
of Pax6;Gli2 Double Mutant Embryos
To further study the mechanisms that are responsible
for distinguishing the fate of p3 and pMN cells, we exam-
ined gene expression in Pax6 and Gli2 mutants that
show opposite defects in the generation of V3 cells in
the thoracic spinal cord. In Pax6sey/sey mutants at em-
bryonic day (E) 10.5, there is a dorsal expansion of
Nkx2.2+ V3 progenitor cells at thoracic and cervical,
but not lumbar, levels (Ericson et al., 1997b; Burrill
et al., 1997) (Figure 2B). In contrast, in homozygous
Gli2 mutants, V3 cells are almost entirely absent in tho-
racic regions (Figure 2C), and Pax6 expression extends
abnormally into the ventral midline (Matise et al., 1998).
In Pax6sey/sey;Gli22/2 double mutants, there was a sub-
stantial rescue of Nkx2.2+ cells in thoracic regions; in
fact, expression extended dorsally beyond its normal
domain, similar to what occurred in Pax6 mutants (Fig-
ure 2D). Thus, in the absence of Pax6, Gli2 alone is no
longer required for Nkx2.2+ V3 progenitor induction in
the thoracic spinal cord.
A Role for the Secreted Wnt Inhibitor sFRP2 in
Regulating Nkx2.2 Expression Downstream of Pax6
Earlier studies of sFRP2 expression in mouse and chick
embryos revealed a dynamic pattern, in which earlywidespread expression (including ventral midline) be-
comes restricted shortly after neural tube closure (Lei-
meister et al., 1998; Terry et al., 2000). To determine
whether sFRP2 could be responsible for the ventral pat-
terning defects in Pax6sey/sey embryos, we analyzed ex-
pression in greater detail in wild-type (wt) embryos and
mutants with abnormal Nkx2.2 expression. In wt em-
bryos at E8.5–10.5, coincident with the first appearance
of Nkx2.2+ progenitors, sFRP2 expression is confined to
the ventricular zone (VZ) in the pMN, p2, p1, and p0 do-
mains and (weakly) in the medial part of the floor plate at
E10.5, but is excluded specifically from the p3 domain
(Figures 2E and 2F; Figure S1, see the Supplemental
Data available with this article online). In agreement
with previous results (Kim et al., 2001), sFRP2 expres-
sion was lost in the thoracic region of Pax6sey/sey mu-
tants (Figure 2G). However, in lumbar regions at E10.5,
where Nkx2.2 expression has not yet expanded dorsally,
robust sFRP2 expression was seen in the absence of
Pax6 (Novitch et al., 2003) (compare inset of Figure 2H
to Figure 2A). Later, at E11.5, when Nkx2.2+ cells expand
dorsally, sFRP2 expression was extinguished (K.M. and
M.P.M., unpublished data). The delayed downregulation
of sFRP2 expression in lumbar regions suggests that
the regulation of sFRP2 by Pax6 is indirect at this level.
To further explore the connection between sFRP2 and
Nkx2.2, we examined expression in mouse Gli mutants
and in compound Pax6;Gli2 mutant embryos. In the tho-
racic region of Gli22/2 mutants, where Nkx2.2+ V3 cells
are nearly totally absent, sFRP2 extended into the ven-
tral midline (Figure 2I). In contrast, in thoracic regions
of Pax6sey/sey;Gli22/2 double mutants, where V3 cells
are rescued (Figure 2D), sFRP2 was not detected (Fig-
ure 2J). Thus, changes in sFRP2 expression are corre-
lated with alterations in Nkx2.2 expression in both Pax6
andGli2mutants, raising the possibility that sFRP2 func-
tions downstream of Pax6 to restrict Nkx2.2 expression
to the p3 domain.
To determine whether sFRP2 expression in the spinal
cord requires Shh signaling, as it does in the developing
somite (Lee et al., 2000), we examined expression in
Gli3xt/xt and Gli22/2;Gli3xt/xt double mutants that lack
all Gli gene function (Bai et al., 2004; Lei et al., 2004). In
Gli3xt/xt mutant embryos, sFRP2 expression was indis-
tinguishable from wt, consistent with the normal devel-
opment of V3/MN progenitors in this mouse (Figure 2K)
(Lei et al., 2004). In Gli22/2;Gli3xt/xt embryos, strong
sFRP2 expression persisted but extended across the
ventral midline, similar to what occurs inGli22/2mutants
(Figure 2L). Thus, sFRP2 expression is activated inde-
pendently of Gli-mediated Shh signal transduction in
the developing spinal cord.
It has also been shown that one of the transcriptional
mediators of Wnt signaling, Tcf4, is downregulated in
the forebrain of Pax6sey/sey mutants (Cho and Dressler,
1998). In the spinal cord, Tcf4 expression encompasses
a similar domain in the VZ as Pax6, and, as in the
forebrain, we found that expression was reduced in
Pax6sey/sey mutants at E10.5 (Figures 2M and 2N). These
findings indicate that the CNS expression of two key
regulators of Wnt signaling depends on normal Pax6
function in developing mouse embryos, suggesting the
possibility that the repression of Nkx2.2 by Pax6 may
be mediated by these two factors.
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328Figure 2. Loss of V3 Cells in Gli2 Mutant Embryos Is Rescued on a Pax6 Mutant Background and Is Correlated to Changes in sFRP2 Wnt
Antagonist Expression
(A–D) Nkx2.2 (p3) progenitor cell patterning changes in the thoracic region of Pax6sey/sey, Gli22/2, and Pax6sey/sey;Gli22/2 mutant embryos at
E10.5. (A) wt expression of Nkx2.2 protein in the p3 domain. (B) Nkx2.2 cells expand dorsally in Pax6sey/sey embryos, as previously shown by
Ericson et al. (1997b). (C) Gli2 mutants have greatly reduced numbers of Nkx2.2+ (p3) cells (arrowhead), as shown by Matise et al. (1998).
(D) In Pax6sey/sey;Gli22/2 double mutants, Nkx2.2 expression is restored but expands dorsally beyond its normal domain, as in Pax6sey/sey single
mutants.
(E–L) Ventrally restricted expression of sFRP2 in progenitor cells in E10.5 embryos. (E) Nkx2.2 (brown) and sFRP2 (purple) are expressed in non-
overlapping, adjacent progenitor domains in thoracic regions of wt embryos at E10.5. (F) sFRP2 is expressed in the motoneuron progenitor do-
main (pMN) that generates Isl1/2+ motoneurons (brown) and extends up to the pd6 domain (see [O]) (data not shown). (G and H) The dorsal ex-
pansion of Nkx2.2 progenitors in E10.5 Pax6sey/sey embryos correlates with changes in sFRP2 expression. In (G) thoracic regions of Pax6sey/sey
embryos, where Nkx2.2 expands dorsally (inset shows a near-adjacent section), sFRP2 expression is absent; in (H) lumber regions, where
Nkx2.2 expression remains in its normal domain (inset), strong sFRP2 expression persists. Weak expression (arrowheads) is maintained in the
floor plate, a tissue that does not normally express Pax6 at this stage. (I) sFRP2 expression extends into the ventral midline in the thoracic region
ofGli22/2 embryos that show a reduction in Nkx2.2+ p3 interneurons (see [C]). (J) sFRP2 expression is absent in the thoracic region ofPax6sey/sey;
Gli22/2 mutant embryos that have rescued Nkx2.2+ progenitors (see [D]). (K) sFRP2 is expressed normally in Gli3xt/xt embryos that do not show
ventral cell patterning defects. (L) Persistent sFRP2 expression in Gli22/2;Gli3xt/xt double mutants.
(M and N) Expression of Tcf4 in VZ progenitors is downregulated in the spinal cord of Pax6sey/sey embryos.
(O) Schematic illustrating the restricted expression of sFRP2 (yellow), Tcf4, and Pax6 relative to the five ventral neuronal progenitor domains in
the embryonic mouse spinal cord at E10.5.
(P–U) Disruption of the p3/pMN domain boundary in sFRP2lacZ/lacZ and Pax6Sey/Sey mutants at E10.5. (P) In wt embryos, the expression of Nkx2.2
and Olig2 forms a sharp boundary to define the p3/pMN junction. (Q) In sFRP2lacZ/lacZ mutants, this sharp boundary does not form, and Nkx2.2+
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329To address whether the defects in p3/pMN boundary
formation seen in Pax6sey/sey mutants are attributable to
the loss of sFRP2 expression, we examined ventral
patterning in targeted sFRP2lacZ/lacZ mutant mice at
E10.5 (T. Sato, personal communication). We found
that Nkx2.2+ and Olig2+ cells were intermingled across
the normally sharp domain boundary in both the
thoracic and lumbar regions (Figures 2P–2U; Figure S1;
n = 4 embryos), and many of the Nkx2.2+ cells in the dis-
rupted boundary region coexpressed Olig2 or Pax6 in
these mutants (Figures 2Q and 2S; Figure S1). In addi-
tion, many Nkx2.2+ cells could be detected well within
the b-gal+ (sFRP2-expressing) pMN domain (Figures
2T and 2U). In comparison, in Pax6 mutants (in which
both sFRP2 and Tcf4 are downregulated), there is a
more prominent expansion of Nkx2.2 into the pMN
territory as well as a disruption of the p3/pMN boundary
and coexpression of Nkx2.2 and Olig2 (Figure 2R). The
expression of Shh and Foxa2 in the floor plate and noto-
chord was not altered in sFRP2lacZ/lacZ mutant embryos
(Figure S1; data not shown). These results provide
evidence that sFRP2 plays a role in establishing the
p3/pMN boundary downstream of Pax6 in the ventral
spinal cord.
sFRP2 Blocks the Gli-Mediated Induction of Nkx2.2
by Suppressing Canonical Wnt Signaling
To further test the role of sFRP2 in distinguishing the fate
of p3 versus pMN cells, we assayed whether it could
alter the induction of these cell types by transfected
DN-Gli2ACT protein in chick embryos (Figures 1, 3A,
and 3B). Cotransfection of a full-length sFRP2 cDNA
(Figure 3N) with DN-Gli2ACT strongly inhibited the induc-
tion of ectopic Nkx2.2+ p3 cells (Figures 3A, 3C, and 3M),
while the induction of Mnr2+, Olig2+ pMN cells was un-
affected (Figures 3B, 3D, and 3M; data not shown). We
next tested whether the N-terminal cysteine-rich domain
(CRD) of sFRP2 was required for this activity, and we
found that deletion of this domain (Figure 3N) rendered
sFRP2 incapable of inhibiting induction of Nkx2.2 by
DN-Gli2ACT (Figures 3E, 3F, and 3M). In contrast, an N-
terminal fragment of sFRP2 containing the CRD domain
(Figure 3N) blocked Nkx2.2 induction as effectively as
the full-length protein (Figures 3G, 3H, and 3M). These
results indicate that the N-terminal CRD domain of
sFRP2 is both necessary and sufficient to prevent the in-
duction of V3, but not MN, progenitor determinants by
DN-Gli2ACT proteins in transfected cells. Since this do-
main is homologous to the extracellular ligand binding
domain of Frizzled receptors, these results raise the
possibility that Wnt signaling status can affect the ability
of Gli2ACT to induce Nkx2.2 expression.The sFRP proteins function extracellularly to interfere
with the binding of Wnt ligands to coreceptors (Ka-
wano and Kypta, 2003); thus, they have the capacity,
in principle, to block canonical and noncanonical signal-
ing pathways. To determine which Wnt signal transduc-
tion pathway was involved in blocking DN-Gli2ACT-
mediated induction of Nkx2.2+ V3 cells, we used an
N-terminally deleted Tcf4 construct (DN-Tcf4) that
cannot bind (and be activated by) b-catenin and thus
functions to dominantly block canonical, but not nonca-
nonical, signaling (Megason and McMahon, 2002) (Fig-
ure 3N). Like sFRP2, cotransfection of DN-Tcf4 with
DN-Gli2ACT efficiently blocked the induction of Nkx2.2,
but not Mnr2 (Figures 3I, 3J, and 3M), consistent with
the idea that sFRP2 functions by inhibiting Tcf-mediated
canonical Wnt signaling in these assays.
We next tested whether dominant repression of Wnt
signaling within the p3 domain could interfere with en-
dogenous Nkx2.2 expression. For this, we examined
sFRP2- and DN-Tcf4-electroporated embryos that had
transfections extending into this domain adjacent to
the floor plate. Significantly, expression of Nkx2.2 was
blocked cell autonomously in GFP+-transfected cells.
In some of these cells, Olig2 expression was seen (Fig-
ures 3K and 3L; data not shown), while markers ex-
pressed in other progenitor domains, including Olig2
and Mnr2 in pMN cells, were not effected (data not
shown). These findings indicate that inhibition of canon-
ical Wnt signaling can block the generation of endoge-
nous Nkx2.2+ cells in the ventral spinal cord under con-
ditions where physiological levels of GliACT proteins are
present (Figure 3O).
Identification of a Mouse Nkx2.2 p3 Enhancer
Containing Conserved Canonical Shh and Wnt
Regulatory Sequences
To further study the mechanism by which the canonical
Shh and Wnt signaling pathways regulate the induction
of p3 versus pMN fates, we examined noncoding re-
gions around the mouse Nkx2.2 gene for potential Gli
and Tcf/Lef binding sequences (Kinzler and Vogelstein,
1990; van de Wetering et al., 1991). A number of highly
conserved regions were found within the locus at which
sequence identity was greater than 70%, and in some
cases approaching 100%, similarity among widely di-
vergent vertebrate species, including human, mouse,
opossum, zebrafish, and Xenopus. Within one such re-
gion, at a position w2 kb upstream of the Nkx2.2 pro-
moter, a single stretch of sequence was identified that
exactly matched the consensus Gli binding site, 50-
GACC(A/T)CCCA-30 (Figure 4A) (Kinzler and Vogelstein,
1990). Comparison of this sequence among a numberand Olig2+ cells intermingle in the boundary region. Some cells in this region inappropriately coexpress Nkx2.2 and Olig2 (arrowheads). In
addition, many Nkx2.2+ cells can be detected within the Olig2 pMN domain (arrows). (R) Nkx2.2 and Olig2 expression in Pax6Sey/Sey mutants.
Although motoneuron differentiation and Olig2 expression are severely compromised in these embryos, Olig2 expression is retained in some
regions of the thoracic spinal cord. In these regions, a disruption of the p3/pMN boundary was observed, including intermingling of Olig2+
and Nkx2.2+ cells and increased coexpression of these factors (arrowheads). (S) Quantification of cells coexpressing Nkx2.2 and Olig2. There
is a significant increase in double-labeled cells in both sFRP2 (p = 0.003) and Pax6 (p = 0.01) mutants compared to wt (n = 10 sections counted for
each genotype). Error bars indicate SEM.(T and U) Nkx2.2+ cells expand into the pMN domain in sFRP2lacZ/lacZ mutants. Comparison of Nkx2.2
expression in sFRP2lacZ/lacZ mutant and sFRP2lacZ/+ heterozygous littermates (that show no phenotype) showing that Nkx2.2+ p3 expression
expands into the pMN territory (bracket), here defined by b-gal expression from the sFRP2 locus, and that individual Nkx2.2+ cells can also
be detected in more dorsal positions within the pMN domain (arrows). Figures show aligned left-right pairs of the same spinal cord section in
different channels to better delineate the b-gal expression boundary, which is indicated by a dashed line.
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330Figure 3. sFRP2 Selectively Blocks the Induction of p3, but Not pMN, Cells by Gli Activators by Inhibiting Canonical Wnt Signaling
(A and B) Transfection of DN-Gli2ACT alone induces widespread ectopic expression of Nkx2.2 (p3) and Mnr2 (pMN) (Lei et al., 2004).
(C and D) Cotransfection of sFRP2 blocks DN-Gli2ACT-mediated induction of Nkx2.2+ p3 cells, but not Mnr2 pMN cells.
(E and F) Deletion of the N-terminal CRD domain that binds to Wnt ligands abolishes the ability of sFRP2 to block Nkx2.2+ p3 cell induction by
DN-Gli2ACT.
(G and H) Cotransfection of the N-terminal CRD domain with DN-Gli2ACT blocks Nkx2.2, but not Mnr2, induction, similar to what is seen with full-
length sFRP2.
(I and J) Cotransfection of dominant-negative DN-Tcf4 with DN-Gli2ACT selectively inhibits Nkx2.2, but not Mnr2, induction, mimicking the effect
of sFRP2.
(K and L) Transfection of sFRP2 or DN-Tcf4 into the p3 domain suppresses expression of Nkx2.2 in transfected cells.
(M) Quantification of data in (A)–(J). Error bars indicate SEM.
(N) Schematic of constructs used in this figure and in Figure 5, and a comparison of sFRP2 to the Frizzled receptor illustrating conserved CRD
domains at the N terminus. The blue boxes indicate the Gro/TLE binding domains.
(O) Summary of results showing that both Wnt and Shh pathway mediators can regulate Nkx2.2 expression.of different vertebrate species revealed conservation of
all 9 residues in the genomes examined (Figure S2).
Within 100 bp upstream of the putative Gli binding site,
we also identified two sequences that closely matched
the core consensus Tcf/Lef binding sequence 50-(A/T)
(A/T)CAAAG-30 (Figure 4A) (van de Wetering et al.,
1991). A similar comparison showed that the putative
Tcf sequences identified in mouse were perfectly con-
served among all mammalian species, and that they
diverged from teleosts and amphibians by only 1 or 2
(zebrafish) residues (Figure S2). Thus, both potential
Gli/Tcf binding sequences have been highly conserved
within the upstream region of Nkx2.2 orthologs across
phyla, raising the possibility that they could be impor-
tant for regulating the patterned expression of this gene.
To test this, we assayed whether a fragment contain-
ing these sites had enhancer activity in transgenicmouse embryos. We isolated a 1.2 kb EcoRI-SacII frag-
ment from Nkx2.2 containing the conserved binding se-
quences (Figure 4A) and cloned this upstream of a lacZ
reporter cassette containing a minimal promoter. In
eight of ten transgenic embryos, lacZ expression was di-
rected specifically in the p3 domain in the spinal cord,
extending rostrally in this domain to the diencephalic/
prosencephalic boundary, while the remaining two em-
bryos showed no staining in the neural tube (Figures
4B–4D; data not shown). On the basis of these results,
we designate this fragment ‘‘Nkx2.2p3e.1’’ for ‘‘Nkx2.2
EcoRI-SacII p3 enhancer element #1.’’
Gli2ACT Induces Nkx2.2 Enhancer Transcription
To test whether Gli proteins could directly regulate
Nkx2.2p3e.1, we used chick transfection assays. When
transfected alone in neural progenitors, significant
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(A) Schematic representation of the mouse Nkx2.2 locus showing the relative location of DNA sequences that closely match Gli (green) and Tcf
(red) consensus binding sites within about 2 kb of the transcription initiation site.
(B–D) E10.5 transgenic mouse embryos generated with a 1.2 kb EcoRI-SacII (E and S) fragment containing putative Gli (green box) and Tcf (red
boxes) binding sites (top). The black box indicates the minimal promoter element. (B and C) X-Gal staining showing b-gal expression in a re-
stricted ventral domain along the entire spinal cord and extending rostrally up to the diencephalic/telencephalic boundary. The dashed line in
(B) indicates the level of section shown in (C). (D) Costaining with antibodies to Nkx2.2 (red) and b-gal (green) shows a nearly perfect overlap
in expression in the p3 progenitor domain.
(E and F) (E) Chick embryos electroporated with DN-Gli2ACT and the Nkx2.2p3e.1 element show upregulation of b-gal expression in a pattern
similar to induced endogenous Nkx2.2 protein. (F) is taken from a near-adjacent section to (E). The right-hand figure in the pair shows the extent
of transfection as revealed by GFP expression in all panels.
(G and H) E10.5 transgenic mouse embryos generated with a modified 1.2 kb EcoRI-SacII fragment in which the putative Gli binding site has been
mutated (gray box in schematic) to create Nkx2.2p3e.1(DGli). b-gal expression was not detected in embryos generated from this construct (7/7).
(I and J) Chick embryos electroporated with the Nkx2.2p3e.1(DGli) construct. b-gal expression can no longer be induced by cotransfection of
DN-Gli2ACT, while ectopic Nkx2.2 was still induced, serving as an internal control for DN-Gli2ACT activity.ectopic lacZ expression was detected in onlyw10% of
the sections examined (7/66; n = 12 embryos), showing
that this construct is largely silent outside of the p3 do-
main in chick embryos (Figure S3). In contrast, transfec-
tion of the reporter with DN-Gli2ACT, which can induce
endogenous Nkx2.2 expression in ectopic locations
throughout the spinal cord (Figure 1A) (Lei et al., 2004),
resulted in upregulation of b-gal expression in a pattern
similar to ectopic Nkx2.2 in all embryos and sections
examined (Figures 4E and 4F; n > 15).
Next, we tested the requirement of the Gli binding site
for reporter expression in both mouse and chick assays.
For this, we modified Nkx2.2p3e.1 by mutating four of
the nine nucleotides within the core sequence to abolish
Gli protein binding (Gustafsson et al., 2002) to generate
Nkx2.2p3e.1(DGli). In transgenic mouse embryos gener-
ated with this construct, b-gal expression was lost from
the p3 domain along the entire neuraxis in all embryos(Figures 4G and 4H) (n = 7/7). We also tested whether
this site was required to induce reporter expression in
chick embryos by cotransfecting Nkx2.2p3e.1(DGli)
with DN-Gli2ACT. Consistent with the mouse results,
lacZ expression was not induced in any of the embryos
examined (n = 6), while ectopic expression of endoge-
nous Nkx2.2 was still elicited, serving as an internal con-
trol for DN-Gli2ACT activity in these experiments (Figures
4I and 4J). Taken together, these findings provide evi-
dence that Nkx2.2 is a direct transcriptional target of
positive Shh-Gli signaling.
Tcf4 Represses Nkx2.2 Transcription
Because Tcf proteins can either activate or repress Wnt
target genes, depending on signaling status, the mere
presence of Tcf/Lef binding sites does not predict
their influence on gene transcription. Both sequences
bound full-length TCF4 protein in EMSA experiments
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(A and B) E10.5 transgenic mouse embryos generated with a 460 bp Xba-SalI (X and Sa) fragment (Nkx2.2p3e.2) encompassing both the putative
Tcf and Gli binding sites (see also Figure S3) in which the putative Tcf sites have been deleted to generate Nkx2.2p3e.2(DTcf) (schematic at top).
Three embryos out of a total of seven generated with this construct show b-gal expression extending dorsally beyond the normal p3 domain.
In the remaining four embryos, expression was similar to what is seen in Figure 4B and Figure S3.
(C–E) Chick embryos electroporated with a Tcf deletion construct generated from the longer EcoRI-SacIINkx2.2p3e.1 fragment, which has lower
background activity in chicks than the shorter one used in mice (see Figure S3). (C) Transfection of theNkx2.2p3e.1(DTcf) construct alone results
in b-gal expression throughout the neural tube in 100% of the sections examined (n = 6 embryos). (D) Cotransfection of DN-Gli2ACT with
Nkx2.2p3e.1(DTcf) induces b-gal expression in a pattern similar to the induction of endogenous Nkx2.2 expression in all embryos (not shown).
(E) Cotransfection of DN-Tcf4 with DN-Gli2ACT and Nkx2.2p3e.1(DTcf) failed to block ectopic b-gal expression in most embryos (72% show
strong lacZ expression, while 28% have weaker levels; none were completely devoid of staining; n = 72 sections in 10 embryos). In contrast,
80% of the sections examined from embryos transfected with the unmodified Nkx2.2p3e.1 construct showed repression of lacZ expression
(n = 39 sections from 5 embryos; data not shown).
(F) DN-Tcf4 repression of Nkx2.2 requires interactions with Gro/TLE corepressors.
(F0) Deletion of the Gro/TLE binding domain from Tcf4 (DGro-Tcf4) rendered it incapable of blocking DN-Gli2ACT-mediated induction of ectopic
Nkx2.2.
(F0 0) Cotransfection of a dominantGrg5 cDNA withDN-Tcf4 (containing the Gro/TLE domain) blocks the ability ofDN-Tcf4 to antagonize induction
of Nkx2.2 by DN-Gli2ACT.(Figure S4). To address the role of the two potential Tcf
sites in regulating Nkx2.2 expression, we tested their re-
quirement in transgenic mouse embryos in the context
of a shorter (450 bp) XbaI-SalI fragment (Figure 4A)
that also drives p3-restricted reporter expression at
a frequency similar to the longer EcoRI-SacII fragment
(7/9 embryos; 2/9 showed no expression); this construct
is designated Nkx2.2p3e.2 (Figure S3). For this purpose,
we generated a construct, Nkx2.2p3e.2(DTcf), in which
the two putative Tcf sites were deleted. In three of seven
transgenic embryos, ectopic b-gal expression was de-
tected throughout the ventral neural tube and extend-
ing into the dorsal spinal cord, while in the remaining
embryos, expression was confined to the p3 domain
(Figures 5A and 5B; data not shown).
We next tested whether the candidate Tcf sites were
required to repress b-gal reporter expression in chicktransfection assays. Because the shorter XbaI-SalI frag-
ment showed a higher incidence of ectopic lacZ activity
in chick electroporation assays (data not shown), we
used the longer Nkx2.2p3e.1 construct in these experi-
ments and deleted the two Tcf sites as described above
to generate Nkx2.2p3e.1(DTcf). Ectopic b-gal expres-
sion was detected in all embryos electroporated with
Nkx2.2p3e.1(DTcf) alone (72/72 sections examined, n =
6 embryos) as well as in all embryos cotransfected
with DN-Gli2ACT (60/60 sections, n = 5 embryos) (Figures
5C and 5D). In addition, cotransfection of DN-Tcf4REP
failed to inhibit DN-Gli2ACT-mediated lacZ reporter ex-
pression from Nkx2.2p3e.1(DTcf), even though induc-
tion of ectopic Nkx2.2 was repressed in the vast majority
of cases (serving as an internal control for Tcf4REP
activity) (Figure 5E; see Figure 3M; data not shown). In
contrast, cotransfection of DN-Tcf4REP with Gli2ACT
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Nkx2.2p3e.1 construct containing both Gli and Tcf sites
(31/39 sections examined, n = 5 embryos; data not
shown). Thus, in the absence of the Tcf binding se-
quences, reporter expression from bothNkx2.2p3e con-
structs is disinhibited, and Tcf4REP proteins lose the
ability to inhibit enhancer activity.
To further define the transcriptional mechanisms in-
volved in the repression of Nkx2.2 by Tcf4, we per-
formed two additional sets of experiments. We first
modified the dominant-negative DN-Tcf4REP construct
to generate DGro-Tcf4REP containing a deletion of the
N-terminal Gro/TLE corepressor binding domain that is
required for transcriptional repression (Brantjes et al.,
2001). When cotransfected with DN-Gli2ACT, DGro-
Tcf4REP was no longer able to block induction of ectopic
Nkx2.2 expression (Figures 5F and 5F0). Finally, we co-
transfected a full-length mouse Grg5 construct to dom-
inantly interfere with the ability of endogenous Gro/TLE
corepressors to associate with transcriptional repressor
proteins containing a TN-Gro/TLE domain (Muhr et al.,
2001). When cotransfected with DN-Tcf4REP and DN-
Gli2ACT constructs, Grg5 prevented the inhibition of
Nkx2.2 induction typically seen under these conditions
(Figures 3I and 5F0 0). Collectively, these results indicate
that DN-Tcf4REP functions as a Gro/TLE-dependent re-
pressor to block Nkx2.2 expression, and they support
the idea that it plays the role of the predicted factor
(‘‘X’’ in Figure 1B) that functions downstream of Pax6
to establish the dorsal boundary of the p3 progenitor
domain (Figure 6).
Discussion
Morphogenetic Shh signaling, mediated by Gli proteins,
controls patterning and cell fate specification within the
ventral neural tube by regulating the differential expres-
sion of a number of transcription factors in neuronal pro-
genitor cells. The results presented in this study reveal
that inhibitory components of the Wnt pathway play
a critical role in controlling the response ofNkx2.2, a ven-
tral Shh-Gli target gene, to graded signaling activity. The
implications of these findings for the regulation of ven-
tral neuronal patterning by morphogenetic Shh signaling
will be discussed below.
Pax6 Regulates Ventral Neuronal Patterning
by Controlling the Expression of Wnt
Signaling Inhibitors
Previous studies have demonstrated important roles for
Pax6 in controlling ventral patterning and the response
of ventral progenitors to graded Shh signaling in the
neural tube (Burrill et al., 1997; Takahashi and Osumi,
2002; Ericson et al., 1997b). In ventral regions of the spi-
nal cord where high levels of Shh are present, Pax6 ac-
tivity is necessary for establishing the p3/pMN bound-
ary, but it appears to function as an activator in this
capacity, predicting the involvement of an intermediate
factor (Briscoe et al., 1999; Muhr et al., 2001). The cur-
rent study implicates sFRP2, a secreted frizzled-related
protein that functions as a Wnt signaling antagonist (Ka-
wano and Kypta, 2003; Galli et al., 2006), and Tcf4, which
encodes a transcription factor of the Tcf/Lef family that
mediates Wnt target gene expression (Hurlstone andClevers, 2002; Brantjes et al., 2002) in this process. In
the absence of Pax6 function, sFRP2 expression is
lost, while Tcf4 is reduced throughout the VZ. In addi-
tion, the p3/pMN boundary is disrupted in targeted
sFRP2lacZ/lacZ mutant mice, although the overall ventral
phenotype is less severe than in Pax6 mutants. The ob-
servation that Tcf4, which our data suggest is the direct
negative regulator of Nkx2.2, is also downregulated in
Pax6 mutants provides a possible explanation for this
difference. In addition, there may be other factors regu-
lated by Pax6 that also participate in modulating Tcf4
repressor levels in ventral cells. For example, sFRP1 is
Figure 6. Model for the Integration of Shh and Wnt Pathway
Elements in Patterning Ventral Cell Types in the Neural Tube
(A) Molecular interactions establishing the p3/pMN domain bound-
ary. Pax6 regulates the expression of both sFRP2 and Tcf4. Tcf4REP
activity within the pMN domain is controlled by sFRP2 and provides
negative regulation of Nkx2.2 expression, thereby setting the dorsal
limit of the p3 progenitor domain. Nkx2.2 repression of Pax6 func-
tions in the reciprocal manner. Nkx2.2 repression of Olig2 depends
on the balance of Gli activators and Tcf repressors in pMN cells
(see text for discussion).
(B) Specification of MN and V3 fates by coordinated regulation of
progenitor genes by transcriptional regulators of the Shh and Wnt
signaling pathways. Differential Tcf activity between the p3 and
pMN domains controls Nkx2.2 expression at the domain boundary;
a positive role in the p3 domain is possible if Tcf activators are gen-
erated here (see Discussion for details). In this model, even a con-
stant level of Shh-Gli activity (red circles) could induce differential
gene expression across the p3/pMN domains if target genes con-
tained distinct complements of Gli and Tcf binding sites.
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cord; however, since its expression pattern in wild-
type embryos does not coincide with the p3/pMN do-
main boundary, it does not likely play an independent
role in its formation (K. Misra & M. Matise, unpublished
data). Because of the possibility of functional redun-
dancy between sFRP1 and sFRP2, it is reasonable to
suggest that the different phenotypes may also be ac-
counted for by loss of both of these factors in Pax6,
but not sFRP2, mutants. These observations suggest
that the net level of Tcf4 repressor in Pax6 mutants is
likely to be significantly lower than in the sFRP2 mutants
alone, and they are consistent with both sFRP2 and Tcf4
functioning downstream of Pax6 to regulate p3/pMN
boundary formation. Taken together, our data support
a model in which sFRP2 locally promotes Tcf4REP activ-
ity to block Nkx2.2 expression in the pMN domain at the
p3/pMN boundary to distinguish these domains (Fig-
ure 6). These findings also suggest that Pax6 controls
ventral patterning by regulating Wnt signaling status in
neuronal progenitors.
Tcf4 Regulates the Response of Nkx2.2 to Positive
Shh-Gli Signaling
Our results reveal that Tcf4 repressors function to antag-
onize the positive activity of Gli activators to control the
dorsal boundary of Nkx2.2 expression in the developing
spinal cord, and they raise the possibility that the inhib-
itory activity of this factor could function to set a thresh-
old level of Shh-Gli signaling required to induce expres-
sion of this gene. Consistent with this possibility,
deletion of the Tcf binding sites from the minimal
Nkx2.2 p3 enhancer results in ectopic reporter expres-
sion dorsal to the p3 domain in both mouse and chicken
embryos in regions where lower levels of Shh signaling
and GliACT activity are presumably present. In addition,
in Pax6 mutants in which sFRP2/TcfREP activity is re-
duced, Nkx2.2+ cells expand dorsally to intermingle
with cells in the V2 domain that are normally induced
at ‘‘medium’’ signaling levels in induction assays (the
fact that not all fates are shifted dorsally indicates that
Shh-Gli activity levels are not altered in these mice) (Eric-
son et al., 1997b). Finally, our results suggest that the
weaker Gli3 (and likely Gli1) activators (Bai et al., 2004;
Lei et al., 2004) are sufficient to induce Nkx2.2+ V3 pro-
genitors when both Pax6 and Gli2 are absent, but not in
Gli2 mutants in which sFRP2 expands into the ventral
midline, suggesting that under conditions of reduced
Tcf4REP activity, Nkx2.2 becomes more sensitive to Gli
activator proteins.
Interestingly, lacZ derepression was seen in only 42%
of transgenic mouse embryos (with the remaining show-
ing normal, p3-restricted expression), but 100% of
transfected chick embryos generated from constructs
with deleted Tcf sites (Figure 5). These results suggest
that Tcf4 repression of Nkx2.2 is especially sensitive to
transgene integration site effects possibly related to epi-
genetic chromatin remodeling (e.g., via Grg and HDAC1
proteins; Nusse, 1999; Brantjes et al., 2001). Moreover,
we cannot exclude the possibility that additional Tcf
(or other negative regulatory) sites not present in the
Nkx2.2 enhancer are involved in repression of Nkx2.2
in the context of the endogenous regulatory elements.
Thus, it is important to point out that our analysis ofenhancer expression may not provide a complete pic-
ture of how p3-restricted expression of Nkx2.2 is
achieved in vivo.
Our data do not rule out the possibility that positive
Wnt-Tcf signaling could contribute to the Shh-Gli-
dependent induction of Nkx2.2 in the p3 domain, nor
do they definitively establish a requirement for this puta-
tive activity. Indeed, misexpression of either sFRP2 or
DN-Tcf4 in this domain is sufficient to block Nkx2.2 ex-
pression, but not pMN markers in the pMN domain, sug-
gesting that an endogenous (canonical) Wnt activity, in
addition to Hh signaling, could be required for Nkx2.2
p3 expression. Furthermore, the observation that Tcf4
expression, but not sFRP2 expression, normally ex-
tends into the p3 domain in wt embryos (Figure 2) sup-
ports the possibility that some Tcf4ACT proteins may
form there if sufficient levels of canonical pathway-acti-
vating ligands are present. Consistent with a possible
synergistic role for Wnt-Tcf activity in inducing Nkx2.2,
widespread constitutive activation of canonical Wnt sig-
naling in chick neural progenitors results in a limited dor-
sal expansion of the Nkx2.2 domain, but not ectopic
expression in the dorsal neural tube (Megason and
McMahon, 2002). Because the two identified Tcf con-
sensus sites are neither sufficient nor required in the
context of the Nkx2.2 p3 enhancer for reporter expres-
sion in the p3 domain (see Figure 4 and Figure S3), Tcf
DNA binding elements located outside the 1.2 kb en-
hancer would likely be involved in this potential function.
Nonetheless, our work, taken together with recent stud-
ies that identified canonical Gli and Tcf binding sites in
conserved noncoding regions of many genes (Hallikas
et al., 2006), suggests that the transcriptional integration
of Shh and Wnt signaling may be a widely employed
strategy for controlling gene expression during develop-
ment and in certain pathological conditions in which
these pathways have been implicated.
Morphogenetic Shh Signaling and Patterning
within the Ventral Neural Tube
In both the developing vertebrate spinal cord and limb
bud, the two embryonic systems in which graded mor-
phogenetic Hh signaling has been the most well studied,
two signaling parameters—strength and duration—
have been shown to exert control over patterning (Eric-
son et al., 1996, 1997a; Stamataki et al., 2005; Harfe
et al., 2004; Ahn and Joyner, 2004). Our results help to
explain this issue in the spinal cord by demonstrating
a mechanism for regulating expression of a Shh-Gli
target gene by an indirect negative feedback loop. The
predicted delay in attenuating the activity of the direct
feedback repressor (Tcf4) that such a regulatory circuit
introduces suggests a mechanism for how both high-
level and prolonged Shh-Gli signaling can activate
Nkx2.2 expression in the neural tube (Stamataki et al.,
2005). In this model, at high (suprathreshold) levels of
Shh-Gli activity, Tcf4REP inhibition of Nkx2.2 would be
directly overridden, and expression would be induced.
This idea is consistent with data showing that inap-
propriate coexpression of Nkx2.2 with pMN markers
(Mnr2 and Olig2) can be achieved under conditions
where high levels of Gli2ACT are driven in transfected
cells. Prolonged exposure to lower-level Shh-Gli signal-
ing would be predicted to function via suppression of
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pression of Nkx2.2 via attenuation of sFRP2/Tcf4REP ex-
pression/activity. This view is supported by previously
published work showing that Pax6 expression can be
repressed by lower concentrations of Shh than those re-
quired to activate Nkx2.2 (Ericson et al., 1997a) and that
downregulation of Pax6 expression in the p3 domain
precedes initiation of Nkx2.2 (Jeong and McMahon,
2005). Together, these observations provide evidence
that Shh-Gli signaling is required to activate Nkx2.2
but is not sufficient on its own to limit its expression to
the p3 domain; rather, they indicate that the dorsal
boundary of Nkx2.2 is controlled indirectly via repres-
sion of Pax6 by Shh, and not by a direct requirement
for high-level Shh-Gli signaling. Thus, they argue against
a simple model in which the differential affinity of Gli
binding sites is sufficient to define the restricted spatial
expression patterns of all targets of graded Shh-Gli
signaling.
Finally, despite evidence that graded Shh-Gli controls
ventral patterning in the spinal cord, it is unclear whether
signaling levels vary sharply enough at progenitor do-
main boundaries to induce distinct sets of genes whose
response is dictated directly and solely by measuring
signaling activity levels. In this case, repression of
Nkx2.2 in the pMN domain would function to prevent co-
activation of p3 and pMN determinants that are sensitive
to a similar level or range of Shh-Gli activity. In this
scenario, compartmentalized TcfREP activity provides
a ‘‘prepattern’’ that determines the response of specific
Shh-Gli target genes, independent of specific differ-
ences in signal strength across the domain boundary.
Experimental Procedures
Animals
Maintenance and genotyping of smalleye (sey) Pax6, extratoes (xt)
Gli3 mutants, targeted Gli2 mutants, and double Gli2;Gli3 mutants
were as described (Ericson et al., 1997b; Matise et al., 1998; Lei
et al., 2004). To generate Pax6;Gli2 double mutant embryos, adults
heterozygous for both Pax6 and Gli2 were intercrossed. Targeted
sFRP2 null mutant mice, generously provided by Dr. Thomas N.
Sato (Weill Medical College of Cornell University), were generated
by replacing the first coding exon with lacZ. The neo selection cas-
sette was removed by crossing founders to CAG-Cre mice, and the
CAG-Cre allele was subsequently removed by out-breeding. Het-
erozygous littermates were intercrossed to generate sFRP2lacZ/lacZ
nulls. A full description of the generation and analysis of this line
will be described elsewhere. For all experiments, at least three
mutant embryos were examined for each genotype.
cDNA Constructs
The following cDNAs were used in chick transfection experiments:
DN-Gli2, DN-Gli3 (Lei et al., 2004), full-length mouse sFRP2 (gift of
J. Nathans), DCRD-sFRP2 (generated by deletion of aa 2–49), Tcf4,
DN-Tcf4 (containing a deletion of aa 2–52) (Tetsu and McCormick,
1999), DGro/TLE-Tcf4 (generated by deletion of aa 2–325).
Identification of a Mouse Nkx2.2 Enhancer and Generation
of Reporter Constructs
Vista Genome (http://pipeline.lbl.gov/servlet/vgb2/) and the UCSC
genome bioinformatics (http://genome.ucsc.edu/) browsers were
used to identify conserved regions in the Nkx2.2 locus across verte-
brate species. Regions of high (>70%) conservation were examined
for the presence of Gli or Tcf consensus sequences. Mouse genomic
sequences upstream of theNkx2.2 gene were amplified by PCR from
mouse 129/SvJ BAC clone AL929317 (NCBI) and subcloned up-
stream of a minimal human b-globin promoter (Yee and Rigby,
1993) and lacZ. The Nkx2.2p3e.1 reporter construct was a 1.2 kbEcoRI-SacII fragment located approximately between 22250 and
21500 from of the transcriptional start site. The Nkx2.2p3e.2 con-
struct was a 450 bp XbaI-SalI fragment (see Figure 4A). Both con-
structs contained the candidate Gli and Tcf sites identified by
sequence conservation. Deletion constructs were made by PCR
modification of these constructs. For the Nkx2.2p3e.1(DGli) con-
struct, four nucleotides within the core wt Gli binding site (50-GAC
CACCCA-30) were mutated (producing 50-GAtgACagA-30; mutated
nucleotides are shown by lowercase letters) (Gustafsson et al.,
2002). For the Nkx2.2p3e.1(DTcf) andNkx2.2p3e.2(DTcf) constructs,
the six core nucleotides within the two putative Tcf sites were
deleted by PCR mutagenesis.
In Ovo Electroporation and Transgenic Mouse Embryo Assays
cDNAs were cloned into bicistronic pCIG (containing GFP) or pCI
(with no GFP) expression vectors (Megason and McMahon, 2002)
and electroporated unilaterally into the neural tube of stage-11 to
stage-13 chick embryos as described (Lei et al., 2004). Embryos
were collected 24 or 48 hr later, and those with strong GFP expres-
sion were processed for immunohistochemistry or in situ hybridiza-
tion. All results shown are representative of those obtained from at
least three embryos for each experiment. The generation of trans-
genic mice and X-gal staining were as described (Jeong and
Epstein, 2003).
EMSA
Myc-tagged human TCF-4E cDNA (gift of F. McCormick) in pCDNA3
was transfected into HEK293 T cells by using Lipofectamine 2000.
Synthetic complementary oligonucleotides were biotinylated with
a 30 end DNA labeling kit (Pierce). Oligonucleotide sequences were
50-caatcggtttgtatttgtgtttgcc-30 (wt TCF#2) and 50-agcttagcaatcgt
ttgtgtttgcc-30 (D-TCF#2) and 50-accgggcctggacaaaggcttccaa-30
(wt TCF#3) and 50-atgcaaaaaccgggcctgcttccaa-30 (D-TCF#3). Unla-
beled target DNA (4 pmol) and either 4 mg nuclear extract or anti-
myc antibody (9E10) (1:10) were added per 20 ml of binding reaction
where indicated.
Immunohistochemistry and In Situ Hybridization
Detection of protein or mRNA in situ was performed as described
(Lei et al., 2004). Antibodies used are: rabbit anti-Pax6 (Chemicon In-
ternational), rabbit anti-Nkx2.2 and anti-Olig2 (gifts of T. Jessell),
anti-bgal (50-30, Inc.); mouse anti-Nkx2.2, anti-MNR2/HB9, anti-
Pax6, anti-Lhx3, anti-Isl1/2 (4D5; gift of T. Jessell). The RNA in situ
probes used are: mouse sFRP2 (gift of J. Nathans), mouse Tcf4
(IMAGE clone 4191488), chicken sFRP2 (gift of L. Burrus), chicken
Tcf4 (EST AB040438; H. Nakamura). Monoclonal mouse antibodies
were obtained from the Developmental Studies Hybridoma Bank
maintained at the University of Iowa and developed under the
auspices of the National Institute of Child Health and Human
Development, unless otherwise indicated.
Supplemental Data
Supplemental data include four figures and are available at http://
www.developmentalcell.com/cgi/content/full/11/3/325/DC1/.
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